Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ARTL will rise by +23.07% over the next 2 Weeks and hit $5.97 by Wednesday, April 8, 2026. In that time frame, ARTL's share price is expected to range between $4.55 and $7.30.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 8, 2026 | 4.55 | 5.97 | 7.30 |
| Apr 7, 2026 | 4.30 | 5.68 | 7.08 |
| Apr 6, 2026 | 4.49 | 5.88 | 7.27 |
| Apr 3, 2026 | 4.34 | 5.66 | 7.12 |
| Apr 2, 2026 | 4.45 | 5.82 | 7.08 |
| Apr 1, 2026 | 4.37 | 5.72 | 7.11 |
| Mar 31, 2026 | 3.97 | 5.43 | 6.93 |
| Mar 30, 2026 | 4.13 | 5.63 | 7.07 |
| Mar 27, 2026 | 3.98 | 5.41 | 6.85 |
| Mar 26, 2026 | 4.04 | 5.57 | 6.92 |
ARTL shares fell -16.23% in Wednesday, March 25, 2026's trading session, dropping from a previous close of $5.79 to move at $4.85. The stock demonstrated notable intraday movement (see ARTL's key stats for a full breakdown), fluctuating between $4.24 and $5.78, a +36.32% trading range. While recent weeks have seen some volatility, ARTL has managed to secure a +24.36% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 3.21M shares changing hands, 2.69M more than the previous session. This amounted to $15.56M in total market activity.
Will ARTL Continue Its Upward Trend?
According to analyst ratings and projections for ARTL, Artelo Biosciences, Inc. shares are anticipated to increase by +33.59%, potentially reaching $7.30 per share by April 8, 2026. Short-term technical indicators currently suggest a bullish sentiment for ARTL. However, the stock has recorded 18 negative trading days within the past 30 sessions. Based on the ARTL stock forecast, now is a good time to buy ARTL stock because its current trading price is -18.74% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ARTL covering social and institutional perspectives.
ARTL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ARTL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.68% to 54.09%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.74%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.58%, maintains a neutral outlook for the long term. Insights into ARTL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Artelo Biosciences Short-Term Forecasts
ARTL Forecast For Next 5 Days
Our algorithm anticipates Artelo Biosciences (ARTL) stock could hit $3.92 by Apr 01, 2026. This represents a -19.20% rise from today's price, following a +18.57% change over the past five days.
ARTL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Artelo Biosciences, Inc. (ARTL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $5.09, which would mean a +4.95% increase from the current price of $4.85. Projections for this period range from a high of $7.59 to a low of $2.87.
ARTL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Artelo Biosciences's price over the next three months point to a drop. ARTL stock is expected to peak at $6.97 on Mar 26, 2026 before potentially dipping to $0.16 on Jun 18, 2026. On average, ARTL is likely to trade around $3.12 in the coming 90 days.
Artelo Biosciences Stock Forecast 2025
Based on our predictive models, Artelo Biosciences (ARTL) is expected to trade between $0.00 and $6.97 throughout 2026. This would result in an average price of $1.33, potentially offering investors a -72.58% return from current levels.
Artelo Biosciences, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Artelo Biosciences, Inc. (ARTL) is positioned to show a strong performance in March 2026. The price is predicted to move between $4.15 and $6.97, settling at an average of $5.61. This could translate to a +15.67% gain.
April 2026
Based on current market signals, Artelo Biosciences, Inc. is projected to trend april 2026. We forecast a trading range from $2.22 to $6.44, with a likely average price of $4.32. Investors could expect a potential return of -10.93%.
May 2026
Our predictive algorithms indicate Artelo Biosciences, Inc. stock may see a shift in May 2026. The expected range spans $0.88–$4.57, with an average target of $2.70. This represents a cautious outlook and a possible loss of -44.33%.
June 2026
Analyzing established trends, Artelo Biosciences, Inc. looks set to move in June 2026. Projections place the stock between $0.11 and $3.29, averaging around $1.63. This suggests a -66.39% loss from current levels.
July 2026
Market indicators suggest Artelo Biosciences, Inc. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $2.56, with a midpoint forecast of $1.07. The stock might deliver a -77.94% loss.
August 2026
Forecasting for August 2026, models estimate that Artelo Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.30, averaging $0.63. This signals a cautious trajectory with potential returns around -87.01%.
September 2026
According to our latest forecast models, Artelo Biosciences, Inc. (ARTL) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $1.84, settling at an average of $0.37. This could translate to a -92.37% loss.
October 2026
Based on current market signals, Artelo Biosciences, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $1.68, with a likely average price of $0.24. Investors could expect a potential return of -95.05%.
November 2026
Our predictive algorithms indicate Artelo Biosciences, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$1.44, with an average target of $0.14. This represents a cautious outlook and a possible loss of -97.11%.
December 2026
Analyzing established trends, Artelo Biosciences, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $1.47, averaging around $0.09. This suggests a -98.14% loss from current levels.
January 2027
Market indicators suggest Artelo Biosciences, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $1.40, with a midpoint forecast of $0.05. The stock might deliver a -98.97% loss.
February 2027
Forecasting for February 2027, models estimate that Artelo Biosciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.49, averaging $0.04. This signals a cautious trajectory with potential returns around -99.18%.
March 2027
According to our latest forecast models, Artelo Biosciences, Inc. (ARTL) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $1.39, settling at an average of $0.02. This could translate to a -99.59% loss.
ARTL's history of dividends and stock splits also plays a role in long-term investor confidence.